@article{a879cb08caf04d7d818932c6b7b4ceb8,
title = "Vaccination in Pregnancy against Pertussis: A Consensus Statement on Behalf of the Global Pertussis Initiative",
author = "Bahaa Abu-Raya and Kevin Forsyth and Halperin, {Scott A.} and Kirsten Maertens and Jones, {Christine E.} and Ulrich Heininger and Daniela Hozbor and {Wirsing von K{\"o}nig}, {Carl Heinz} and Chitkara, {Amar J.} and Rudzani Muloiwa and Tan, {Tina Q.}",
note = "Funding Information: The Global Pertussis Initiative is supported by Sanofi. It was established in 2001 to evaluate the ongoing pertussis challenges across the globe and recommend appropriate pertussis control strategies. Sanofi continues to fund this important initiative to provide a forum for scientific-, clinical-, and policy-based discussions. The views and opinions expressed in this publication, which could include the usage of Sanofi products that are inconsistent with the current labeling or licensed indication, are solely those of the authors and do not reflect the position of Sanofi. BA was funded by Michael Smith Health Research BC. Funding Information: The authors are scientific experts and, as such, received honoraria for their participation in this live meeting from Sanofi. In addition, Heininger, U., was a member of the Collaboration of European Experts on Pertussis Awareness Generation (CEEPAG; he was a group member until 2021), and he has received honoraria for participation in previously associated live meetings from Sanofi, USA and Sanofi, France, respectively, as well as receiving honoraria for educational activities from Pfizer, MSD, and InfectoPharm. Forsyth, K., and Chitkara, A.J., have also previously received honoraria from Sanofi. Tan, T.Q., has received grants from Merck and Sanofi and personal fees from GSK Biologicals and Sanofi, and honoraria from Sanofi. Wirsing von K{\"o}nig, C.H., has received honoraria for attending meetings sponsored by Sanofi, GSK Biologicals SA, MSD, and Novartis Vaccines. Halperin, S.A., has received contracts for clinical trials and served on ad hoc advisory boards for Sanofi and GSK. Muloiwa, R., has received honoraria for educational activities from MSD and Sanofi. The authors declare no other conflict of interest. Publisher Copyright: {\textcopyright} 2022 by the authors.",
year = "2022",
month = dec,
doi = "10.3390/vaccines10121990",
language = "English",
volume = "10",
journal = "Vaccines",
issn = "2076-393X",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "12",
}
